Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lothe

Showing results (231-240 of 286) with videos related to

Pageof 29
Sort By:
Oncogenesis|May 17, 2019
Transcriptional and functional consequences of TP53 splice mutations in colorectal cancerJørgen Smeby, Anita Sveen, Ina A Eilertsen, et al.
International Journal of Molecular Medicine|September 20, 2001
A germline E-cadherin mutation in a family with gastric and colon cancerS Salahshor, H Hou, C B Diep, et al.
Neuro-Oncology|December 7, 2013
Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumorsAnnette B Håvik, Guro E Lind, Hilde Honne, et al.
Stem Cell Reports|November 29, 2013
BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell culturesStuart Avery, Adam J Hirst, Duncan Baker, et al.
The British Journal of Surgery|April 16, 2025
Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancerSeyed H Moosavi, Kushtrim Kryeziu, Ina A Eilertsen, et al.
Plos One|November 28, 2012
Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinomaMaria J Camões, Paula Paulo, Franclim R Ribeiro, et al.
International Journal of Cancer|May 26, 2017
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancersHege Marie Vedeld, Marianne Merok, Marine Jeanmougin, et al.
Cancer Letters|December 17, 2016
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1João Ramalho-Carvalho, João Barbosa Martins, Lina Cekaite, et al.
JCI Insight|January 4, 2024
Evolutionary mode and timing of dissemination of high-grade serous carcinomasAnita Sveen, Bjarne Johannessen, Solveig Mk Klokkerud, et al.
Neuro-Oncology|February 3, 2009
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumorsHelge R Brekke, Matthias Kolberg, Rolf I Skotheim, et al.
Pageof 29

Showing results (231-240 of 286) with videos related to

Sort By:
Pageof 29
Oncogenesis|May 17, 2019
Transcriptional and functional consequences of TP53 splice mutations in colorectal cancerJørgen Smeby, Anita Sveen, Ina A Eilertsen, et al.
International Journal of Molecular Medicine|September 20, 2001
A germline E-cadherin mutation in a family with gastric and colon cancerS Salahshor, H Hou, C B Diep, et al.
Neuro-Oncology|December 7, 2013
Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumorsAnnette B Håvik, Guro E Lind, Hilde Honne, et al.
Stem Cell Reports|November 29, 2013
BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell culturesStuart Avery, Adam J Hirst, Duncan Baker, et al.
The British Journal of Surgery|April 16, 2025
Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancerSeyed H Moosavi, Kushtrim Kryeziu, Ina A Eilertsen, et al.
Plos One|November 28, 2012
Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinomaMaria J Camões, Paula Paulo, Franclim R Ribeiro, et al.
International Journal of Cancer|May 26, 2017
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancersHege Marie Vedeld, Marianne Merok, Marine Jeanmougin, et al.
Cancer Letters|December 17, 2016
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1João Ramalho-Carvalho, João Barbosa Martins, Lina Cekaite, et al.
JCI Insight|January 4, 2024
Evolutionary mode and timing of dissemination of high-grade serous carcinomasAnita Sveen, Bjarne Johannessen, Solveig Mk Klokkerud, et al.
Neuro-Oncology|February 3, 2009
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumorsHelge R Brekke, Matthias Kolberg, Rolf I Skotheim, et al.
Pageof 29